Kategorie: english

One of Germany’s largest daily newspapers FAZ has published a portrait on Eurox Group, highlighting our pharmaceutical and business accomplishments.

Medical cannabis has been allowed to be prescribed to patients for five years. Several start-ups from the Rhine-Main region have been involved since the beginning – and hope for further legalization.

As one of the leading European vertically-integrated companies developing and manufacturing cannabis based medicines, Eurox Group, based in Hesse, Germany, has successfully fundraised €4,4 Million from new and existing investors at an approximate 62% premium to its July 2021 fundraise.

Eurox Pharma prioritizes research and development. In collaboration with physicians, pharmacists and research, the company aims to produce evidence-based products that meet the specific needs of patients, rather than simply marketing another cannabis product as profitably as possible.

Last year was the year of megarounds for cannabis startups…

Eurox Pharma is a vertically integrated company with roots in the German and European production of herbal medicines. From this tradition, Eurox also ensures the highest quality along the entire value chain for medicinal cannabis extracts and the active ingredient dronabinol.

Eurox Pharma manufactures cannabis-based medicines and products in a state-of-the-art facility in Germany. The company relies on cutting-edge research and complies with the highest pharmaceutical quality and safety standards in Germany and the EU for operations and products.

Sales of Δ9-THC represents a new revenue stream for Eurox, which follows the distribution agreement of Eurox’s full-spectrum extracts to pharmacies during the previous calendar quarter.

Experts in the field of medical cannabis, including Eurox Group’s very own Mike Kindrat present at the Royal Society of Medicine.

Neil Smith, 56, is the chairman of Germany-based firm Eurox Pharma and CEO of the Integro Medical Clinic.